Home  »  Finance   »  Check out this: 180 Life Sciences Corp. (ATNF) cou...

Check out this: 180 Life Sciences Corp. (ATNF) could be on the verge of a big rally

180 Life Sciences Corp. (NASDAQ: ATNF) is -68.72% lower on its value in year-to-date trading and has touched a low of $0.79 and a high of $8.90 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ATNF stock was last observed hovering at around $1.19 in the last trading session, with the day’s gains setting it 0.03% off its average median price target of $5.00 for the next 12 months. It is also 75.6% off the consensus price target high of $5.00 offered by 1 analysts, but current levels are 75.6% higher than the price target low of $5.00 for the same period.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Currently trading at $1.22, the stock is 9.96% and 1.97% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.11 million and changing 2.52% at the moment leaves the stock -55.77% off its SMA200. ATNF registered -83.86% loss for a year compared to 6-month loss of -62.75%. The firm has a 50-day simple moving average (SMA 50) of N/A and a 200-day simple moving average (SMA200) of -$15.29.

The stock witnessed a 35.42% gain in the last 1 month and extending the period to 3 months gives it a -8.27%, and is 10.91% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.28% over the week and 10.26% over the month.

Distance from 52-week low is 54.43% and -86.29% from its 52-week high.

180 Life Sciences Corp. (ATNF) Analyst Forecasts

Analyst recommendations provided by FactSet shows that the consensus forecast for 180 Life Sciences Corp. (ATNF) is a “Hold”. 1 analysts offering their recommendations for the stock have an average rating of 3.00, where 1 rate it as a Hold and 0 think it is a “Overweight”. 0 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.

180 Life Sciences Corp. is expected to release its quarterly report on 11/30/2022.The EPS is expected to grow by 2.00% this year.

180 Life Sciences Corp. (ATNF) Top Institutional Holders

The shares outstanding are 34.50M, and float is at 22.08M with Short Float at 4.08%.

180 Life Sciences Corp. (ATNF) Insider Activity

A total of 4 insider transactions have happened at 180 Life Sciences Corp. (ATNF) in the last six months, with sales accounting for 0 and purchases happening 4 times. The most recent transaction is an insider purchase by Vu Quan Anh,the company’sCOO / Chief Business Officer. SEC filings show that Vu Quan Anh bought 8,000 shares of the company’s common stock on Dec 16 at a price of $3.98 per share for a total of $31840.0. Following the purchase, the insider now owns 20500.0 shares.

180 Life Sciences Corp. disclosed in a document filed with the SEC on Dec 10 that Pamir Ozan (Interim CFO) bought a total of 3,800 shares of the company’s common stock. The trade occurred on Dec 10 and was made at $3.87 per share for $14706.0. Following the transaction, the insider now directly holds 76408.0 shares of the ATNF stock.

Still, SEC filings show that on Dec 10, Marrone Pamela G (Director) acquired 1,000 shares at an average price of $4.10 for $4100.0. The insider now directly holds 1,000 shares of 180 Life Sciences Corp. (ATNF).

Related Videos

Most Popular

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Related Posts




The 5 Best Inflation Stocks for 2022

100% free. stop anytime no spam

Get our free report on the stocks that we recommend for investors who want to protect their portfolios from inflation.